Zivo Bioscience, Inc.
ZIVO
$17.80
-$0.10-0.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.31% | -297.78% | 35.20% | 27.73% | 8.95% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,372.78% | 12,917.26% | -1.44% | -90.21% | -69.10% |
| Change in Net Operating Assets | 120.70% | -95.94% | -89.24% | 684.24% | -258.86% |
| Cash from Operations | 44.91% | 36.73% | 20.19% | 50.54% | -32.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -14.53% | -- | -- |
| Total Debt Repaid | 14.56% | 14.56% | 14.56% | -819.54% | 3.63% |
| Issuance of Common Stock | -61.09% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.82% | -38.92% | 190.43% | -253.97% | 1,738.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.28% | 27.36% | 91.47% | 23.72% | 186.21% |
